Anders Kvanta

About me

Adjunct professor in ophthalmology and senior staff member in vitreoretinal surgery

Research description

We are conducting experimental and clinical studies focused on identifying and improving treatments of several retinal diseases, including retinal degenerations, retinal vein occlusion and diabetic retinopathy. Our experimental projects include molecular and cell biology studies, and preclinical animal models aimed to identify new molecules and pathways relevant to the onset of neovascularization and cell death for these retinal conditions. In addition, preclinical studies are ongoing with gene therapy to treat vascular retinal diseases. In the clinics, studies are conducted maintaining the translational goal to halt complications of pathologic neovascularization in macular degeneration, retinal vein occlusion and diabetic retinopathy. A first-in-human clinical trial on gene therapy for hereditary retinal degeneration is ongoing. In a joint translational project, we use differentiated embryonic stem cells to replace lost retinal cells in an attempt to treat severe forms of retinal degeneration with a first-in-human clinical trial in development.